Source: CNNMoney.com
Posted: April 5, 2007: 11:43 AM EDT
Summary:
Two new stem cell treatments could be entering the U.S. market next year. Two biotechs, Cytori Therapeutics and Osiris Therapeutics, each hope to get their experimental stem cell products approved by the Food and Drug Administration and into the U.S. market by 2008. Both outfits work with stem cells that are derived from adult tissue, not embryos, so they're insulated from the controversy surrounding the use of stem cells harvested from human embryos.
